PVT1 and ischemic stroke: Inspired by the altered plasma levels of lncRNA PVT1 (plasmacytoma variant 1) and miR-214 in ischemic stroke patients, Lu et al. [20] investigated the therapeutic effects of targeting PVT1 and miR-214 in cerebral I/R models.